Clinical trial
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's…
NCT00352261 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00352261 |
|---|---|
| Title | An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients |
| Official title | An Open-Label, 2-Way Crossover Study of Steady-State Intragastric pH Control Comparing 2 Dosage Regimens of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Barrett's Esophagus |
| Intervention type | Drug |
| Interventions | Esomeprazole, Lansoprazole |
| Enrollment | 80 |
| Start date | Jan 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | Mar 26, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: